Severe pembrolizumab-induced gastritis in a patient with lung adenocarcinoma

Cancer immunotherapy is an increasingly common treatment option based on anti-tumor immune response. However, a challenge is arising regarding its potential, which is the poorly understood recognized immune-mediated adverse effects.

Bibliographic Details

Published in:	Revista española de enfermedades digestivas Vol. 114; no. 2; pp. 127 - 128
Main Authors:	Pérez Santamaría, Cristina, Castillo-López, Guillermo, Curto García, Isabel, Gómez Iglesias, Patricia, Lumbreras Cabrera, Mercedes, Carreira Guillán, Lourdes
Format:	Journal Article
Language:	English Spanish
Published:	Spain Sociedad Espanola de Patologia Digestivas 01-02-2022
Subjects:	Adenocarcinoma of Lung - chemically induced Adenocarcinoma of Lung - drug therapy Antibodies, Monoclonal, Humanized - adverse effects Gastritis - chemically induced Humans Lung Neoplasms - drug therapy Lung Neoplasms - pathology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!